TCT 2022 | AMULET IDE: Events at 3 Years Using the AMULET Appendage Closure Device

The aim of this study was to assess the 3-year efficacy for the endpoints of the AMULET Occluder (Abbott) left atrial appendage closure device compared with the Watchman 2.5 device.

TCT 2022 | AMULET IDE: Eventos a 3 años con el dispositivo de cierre de orejuela AMULET

The evaluated endpoints were analyzed according to a “per protocol” population, assessing a composite of stroke, systemic embolism, or cardiovascular death. The secondary endpoints were all-cause mortality and cardiovascular death, major bleeding, and a composite of ischemic stroke or systemic embolism.

A total of 917 Amulet Occluder implants and 916 Watchman device implants were observed. The mean age was 75 years old; 58% of patients were male, 55% of whom had paroxysmal atrial fibrillation, with a CHA2DS2-VASC of 4.6.

After a 3-year follow-up, the use of oral anticoagulants was lower with Amulet both at 18 months (3.1% vs. 5.6%; p = 0.01) and at 3 years (3.7% vs. 7.3%; p < 0.01). When analyzing the composite endpoint of stroke, systemic embolism, and cardiovascular death, there was no significant reduction (hazard ratio [HR]: 0.87; 95% confidence interval [CI]: 0.66-1.14; p = 0.31). There was evidence of a non-significant lower trend in all-cause mortality (HR: 0.81; 95% CI: 0.64-1.02; p = 0.07).

Read also: Primary vs Secondary Retrograde Approach in CTO: Differences.

Moreover, the study yielded similar rates for major bleeding events, defined as BARC 3 or more (HR: 1.09, 95% CI: 0.86-1.39; p = 0.46), and thromboembolic events (HR: 1.09; 95% CI: 0.70-1.70; p = 0.69).

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Font: 3-Year Outcomes from the AmplatzerTM AmuletTM Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE). Presentado por Dhanunjaya Lakkireddy en TCT Congress, Boston, EE. UU. 17 septiembre de 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...